<DOC>
	<DOCNO>NCT00606957</DOCNO>
	<brief_summary>The reason study learn whether raise person 's vitamin D level normal normal level improve body 's ability use sugar . Vitamin D well know important vitamin development maintenance bone . Recently , scientist learn vitamin D may role prevention cancer , diabetes , autoimmune disease . The investigator specifically interested study question overweight/obese population great risk vitamin D deficiency impair ability metabolize sugar ( glucose intolerance ) . Primary Hypotheses : Vitamin D repletion ( increase serum 25 ( OH ) D level ≤ 20 ng/ml ≥ 30 ng/ml ) improve insulin sensitivity individual overweight/obese insulin resistant . Secondary Hypotheses : 1.Vitamin D repletion improve biomarkers cardiovascular risk inflammation ( directly alter macrophage cytokine production and/or indirectly result improvement insulin sensitivity . ) 2.30,000 IU ( 0.25 mg ) weekly cholecalciferol ( vitamin D3 ) raise serum 25 ( OH ) D level ≤ 20 ng/ml ≥ 30 ng/ml overweight/obese population .</brief_summary>
	<brief_title>The Effect Vitamin D Repletion Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Nonsmoking men woman , age 1865 Body mass index ( BMI ) ≥ 28 kg/m² within 10 % maximum weight Serum 25 ( OH ) D level ≤ 20 ng/ml Serum insulin level ≥ 7.2 mU/l Willingness maintain current body weight duration study Willingness maintain baseline lifestyle activity routines duration study Willingness avoid use nonsteroidal antiinflammatory drug ( NSAIDS ) , include lowdose daily aspirin , least ten day prior admission ( due potential effect agent inflammatory marker . ) Willingness avoid use overthecounter prescription vitamin , dietary supplement , herbal product study , exception basic multivitamin supplement . If childbearing potential , willingness use highly effective contraception duration study . Current tobacco smoke History bleed coagulation disorder Gastrointestinal disease result significant gastrointestinal dysfunction malabsorption History diabetes , diagnose screen OGTT Current treatment hypertensive medication History cardiovascular disease Renal disease , evidence serum creatinine upper limit normal one screen visit History kidney stone History chronic hepatitis , liver enzymes ( AST ALT ) 2.5 time upper limit normal Primary hyperparathyroidism baseline hypercalcemia cause Current treatment overthecounter prescription weight loss medication , orlistat sibutramine History bariatric surgery Current treatment cholesterollowering medication , statin , niacin , fibrates , ezetimibe Blood pressure ≥ 145/90 ten minute rest one screen visit Hyperthyroidism untreated hypothyroidism . Subjects chronic , treated , stable hypothyroidism may include study discretion Principal Investigator . Pregnancy , desire pregnancy , lactation within study period . HIV , Hepatitis B C Medical condition require daily calcium supplementation antacid use Use medication know interact calcium vitamin D metabolism ( bisphosphonates , corticosteroid , thiazide diuretic , cholestyramine , colestipol , mineral oil , phenytoin , barbituates , dititalis glycoside , antacid ) Subjects know hypersensitivity cholecalciferol Participation investigational drug study within one month screen History , physical , laboratory finding suggestive medical psychological condition would , opinion principal investigator , make candidate ineligible study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Metabolism</keyword>
</DOC>